Research and technology development industries, from pharmaceuticals and life sciences to consumer goods and agroscience, remain in an era of explosive growth with tremendous opportunity for innovation and investment. At the same time, both the incumbents and new entrants are facing tremendous challenges given the new realities of the economy.
In this white paper, learn how world-class innovation teams create standard frameworks to evaluate and prioritize the strategic investments that deliver the highest returns on investment, streamlining and accelerating the R&D portfolio planning process.
A New Paradigm for R&D Prioritization
Source: Decision Lens
